Eagle Pharmaceuticals to Complete Nasdaq Delisting After Trading Suspension - Stock Titan
2024-11-15 • Google News
Eagle Pharmaceuticals Inc (EGRX)
US$ 18.053.5%
Price Chart
Key Statistics
Market Cap
$ 25.14M
P/E Ratio
2.28
Revenue (TTM)
$ 257.55M
Volume
99.47K
52W High
$ 6.37
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
0.64
Technicals
50-Day MA
1.5455
200-Day MA
1.7838
52 Week High
6.37
52 Week Low
0.0025
About EGRX
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and onco.
Employees
134
Headquarters
Woodcliff Lake, NJ
CEO
Mr. Michael Graves
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg